

Cover Story
SWOG earlier this week started to accrue patients to Lung-MAP, a clinical trial for second-line treatment of non-small cell lung cancer.
By Tessa Vellek
In Brief


Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- White House announces “TrumpRx,” a new prescription drug website
- Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill